LogiNext Presents World’s First Complete COVID-19 Vaccine Supply Chain Management Platform Kumar Jeetendra | December 15, 2020 Mumbai, INDIA – December 15, 2020 – LogiNext today announced the launch of a COVID -19 vaccine supply chain management and tracking platform. With several parts of the globe in the grips of a second or third wave of the COVID-19 pandemic, vaccine trials are on and a reliable supply chain mechanism for the vaccine …
Alembic Pharmaceuticals gets USFDA endorsement for Asenapine Sublingual Tablets Kumar Jeetendra | December 12, 2020 Alembic Pharmaceuticals announced it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Asenapine Sublingual Tablets, 5 mg and 10 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Saphris Sublingual Tablets, 5 mg and 10 mg, of Allergan Sales, LLC …
Cipla announces settlement of Revlimid® (Lenalidomide) capsules patent Litigation Kumar Jeetendra | December 11, 2020 Mumbai, India, December 11, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) (“Cipla”) today announced the settlement of its litigation with Celgene Corporation, and wholly owned subsidiary of Bristol Myers Squibb (NYSE: BMY) relating to patents for REVLIMID® (lenalidomide). As part of the settlement, the Parties will file Consent Judgments with the United States District …
Sanofi and GSK defer COVID-19 antibody, marking setback to worldwide battle Kumar Jeetendra | December 11, 2020 The announcement on Friday, which emphasized the challenges of developing shots at record speed, hinders attempts to develop the multiple options that experts say that the world needs to cancel a disease that has killed over 1.5 million people. The news, which came on the same day as Australia axed a domestic vaccine project, can …
UK cautions individuals with serious allergies to maintain a strategic distance from Pfizer vaccine after two unfavorable responses Kumar Jeetendra | December 10, 2020 Britain’s medication regulator said anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine, giving more advice on an earlier allergy warning about the shot. Starting with the elderly and frontline workers, Britain began mass vaccinating its population on Tuesday, part of a worldwide drive that poses …
Pfizer plans layered pricing in India, free shots in Africa Kumar Jeetendra | December 9, 2020 Pfizer Inc has decided to price its COVID-19 vaccine candidate, BNT162b2 COVID-19, on the basis of the GDP of the country. The Chief Executive Officer of the American pharmaceutical company, Albert Bourla, has said the company will have tiered pricing to its middle-income nations, including India. The COVID-19 vaccine developed by Pfizer and BioNTech was …
Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its corona vaccine Kumar Jeetendra | December 7, 2020 China’s Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its coronavirus vaccine, the companies said on Monday, as it anticipates efficacy data of its experimental shot this month. The investment deal also comes as Sinovac expands provide deals and trials of its experimental COVID-19 vaccine CoronaVac …
Pfizer Seeks Emergency Use approvals For Its COVID-19 Vaccine In India Kumar Jeetendra | December 6, 2020 Pfizer India has submitted an application on December 4 to the DCGI hunting emergency use authorization (EUA) for its COVID-19 vaccine in India. The firm has filed the EUA program in Form CT-18 for grant of permission to import and market Pfizer-BioNTech’s COVID-19 mRNA vaccine BNT162b2 in the nation,” the source said, citing the program. …
Artificial Intelligence, Machine Learning To Play an important Role In Fight Against COVID, Say Experts Kumar Jeetendra | December 5, 2020 Artificial intelligence (AI) and machine learning are helping analyse enormous amounts of data around the human genome and drug molecules, and these new-age technologies can play an important role in the battle against COVID-19, industry experts said on Saturday. Speaking at KnowDis Machine Learning Day, Avantika Lal – Senior Scientist (Deep Learning and Genomics) at …
Fermenta Biotech USA, LLC acquires 52% interest in AGD Nutrition LLC Kumar Jeetendra | December 5, 2020 Fermenta Biotech Limited (FBL), India has announced that its wholly owned subsidiary Fermenta Biotech USA LLC (FBU), Wilmington, DE, has acquired a 52% stake in a US-based vitamin company, AGD Nutrition LLC (AGD), headquartered in Nacogdoches, Texas. The deal would combine the expertise of both companies and result in synergies that will bring in greater …
DT-109 Significantly Prevents Progression of Diet-Induced Non-Alcoholic Fatty Liver Disease Kumar Jeetendra | December 4, 2020 Ann Arbor, MI – December 4, 2020 – Life Science Newswire – Rom et al report today that the oral administration of the simple tri-peptide, DT-109 (Patent US8664177B2), prevents both development of non-alcoholic fatty liver disease (NAFLD) and late stage fibrosis in a murine model of diet-induced non-alcoholic steatohepatitis (NASH). The study titled, “Glycine-based treatment …
Rhizen Pharma gets USFDA endorsement for stage one clinical preliminaries for Covid-19 drug Kumar Jeetendra | December 3, 2020 New Delhi, Dec 2 (PTI) Rhizen Pharmaceuticals, a member firm of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regulator to commence phase one clinical trials on retroviral oral drug for the treatment of COVID-19. The Switzerland-based firm, which will be a clinical-stage oncology-focussed biopharmaceutical company, has obtained approval for …
